These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8725567)

  • 1. At risk nephrons and the decline in renal function in response to treatment of hypertension.
    Walker WG; Ford C
    Trans Am Clin Climatol Assoc; 1996; 107():134-43; discussion 143-5. PubMed ID: 8725567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
    Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
    Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy.
    Parving HH; Andersen AR; Smidt UM; Svendsen PA
    Lancet; 1983 May; 1(8335):1175-9. PubMed ID: 6133986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
    Pedersen MM; Christensen CK; Hansen KW; Christiansen JS; Mogensen CE
    Clin Invest Med; 1991 Dec; 14(6):642-51. PubMed ID: 1665407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of carvedilol on pulse pressure and left ventricular hypertrophy in spontaneously hypertensive rats with adriamycin nephropathy.
    Jovanovic D; Jovovic D; Mihailovic-Stanojevic N; Miloradovic Z; Naumovic R; Dimitrijevic J; Maksic N; Djukanovic L
    Biomed Pharmacother; 2009 Sep; 63(8):571-6. PubMed ID: 19013753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of antihypertensive treatment on kidney function in insulin-dependent (type I) diabetics with renal failure.
    Zander E; Conde N; Heinke P; Zander G; Strese J; Gums G; Schulz B
    Exp Clin Endocrinol; 1990 Feb; 95(1):70-6. PubMed ID: 2335182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rate of change in renal function and mortality in elderly treated hypertensive patients.
    Chowdhury EK; Langham RG; Ademi Z; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1154-61. PubMed ID: 25901093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of loss of renal function over time in patients with diabetic nephropathy.
    Barnett A
    Am J Med; 2006 May; 119(5 Suppl 1):S40-7. PubMed ID: 16563947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun; 349(9069):1857-63. PubMed ID: 9217756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
    Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
    Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of multiple factorial intervention on ambulatory BP profile and renal function in hypertensive type 2 diabetic patients with overt nephropathy - a pilot study.
    Kanaoka T; Tamura K; Moriya T; Tanaka K; Konno Y; Kondoh S; Toyoda M; Umezono T; Fujikawa T; Ohsawa M; Dejima T; Maeda A; Wakui H; Haku S; Yanagi M; Mitsuhashi H; Ozawa M; Okano Y; Ogawa N; Yamakawa T; Mizushima S; Suzuki D; Umemura S
    Clin Exp Hypertens; 2011; 33(4):255-63. PubMed ID: 21699452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal autoregulation and passive pressure-flow relationships in diabetes and hypertension.
    Hill JV; Findon G; Appelhoff RJ; Endre ZH
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F837-44. PubMed ID: 20660017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High salt intake promotes a decline in renal function in hypertensive patients: a 10-year observational study.
    Ohta Y; Tsuchihashi T; Kiyohara K; Oniki H
    Hypertens Res; 2013 Feb; 36(2):172-6. PubMed ID: 23051657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
    Ellis D; Moritz ML; Vats A; Janosky JE
    Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parallel-group 8-week study on chlorthalidone effects in hypertensives with low kidney function.
    Cirillo M; Marcarelli F; Mele AA; Romano M; Lombardi C; Bilancio G
    Hypertension; 2014 Apr; 63(4):692-7. PubMed ID: 24396024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.